SCM joins eight mainland enterprises to establish synergistic innovation platform

29 May 2015

 

The School of Chinese Medicine (SCM) held an opening ceremony for the "University-Enterprise Synergy Innovation Platform" in Hong Kong Science Park on 26 May. The platform, jointly established by SCM and the industry to serve as a base for comprehensive cooperation, marks yet another milestone in SCM's development.

Officiating at the opening ceremony were Mr Vincent Tang, Assistant Commissioner, Innovation and Technology Commission; Dr Wang Yanmei, Secretary General, Shenzhen Life Science and Biotechnology Association; Professor Rick Wong, Acting President and Vice-Chancellor, HKBU; Professor Lu Aiping, Dean of SCM; Dr Zhang Ge, Director of Technology Development Division, SCM; and representatives of eight partner organisations.

In his speech, Professor Rick Wong said that the School has attained encouraging achievements in the areas of Chinese medicine education, research, knowledge transfer and medical services since its establishment. Since SCM shares with the partner organisations the same vision and objective of inventing new drugs, promoting modernisation of Chinese medicine and benefiting public health, it is envisaged that the collaboration would bring forth fruitful results and contribute to the realisation of the national strategies for fostering the development of medical services, healthcare, education, research and manufacturing, as well as international exchange and cooperation in Chinese medicine.

The platform is housed in the SCM laboratories in Hong Kong Science Park and SCM Building. The collaboration enables consolidation and optimisation of talents and scientific resources of SCM and the partner organisations to conduct innovative integrated research on Chinese medicine, with a view to building a world-class, multi-disciplinary platform for innovative research and inventing new drugs and health products which have wide application prospects. Through this collaboration, SCM and its partners hope to enhance the Chinese medicine manufacturing industry in the region and foster the development of Chinese medicine for the benefit of mankind.

The partner organisations involved in this platform include the National Engineering Research Centre for Modernisation of Traditional Chinese Medicine, Kunshan Technology Research Institute Small Nucleic Acid Biotechnology Research Institute, Qingfeng Pharmaceutical Group, Junlan Electronic (HK) Limited, Guizhou Yibai Pharmarceutical Company Limited, Consun Pharmaceutical Group Limited, Zhangzhou Pien Tze Huang Pharmaceutical Company Limited, and Shenzhen Tsumura Medicine Company Limited.

In addition, the Shenzhen Life Science and Biotechnology Association arranged a delegation of 12 Shenzhen biomedical or related organisations to attend the ceremony, and representatives from three other mainland enterprises were also present. Later, guests met with SCM research teams at an interactive forum to explore the feasibility and areas of cooperation. Furthermore, SCM was invited to participate in a few projects now being drafted by the Shenzhen Municipal Government, and received invitation from four enterprises, two research institutes and two hospitals to visit and explore collaboration in different aspects.

Mr Vincent Tang, Assistant Commissioner, Innovation and Technology Commission (sixth from left); Professor Rick Wong, Acting President and Vice-Chancellor, HKBU (seventh from left); Dr Wang Yanmei, Secretary General, Shenzhen Life Science and Biotechnology Association (eighth from left); Professor Lu Aiping, Dean of SCM (far left); Dr Zhang Ge, Director of Technology Development Division, SCM (far right); and representatives of partner organisations officiate at the opening ceremony.

Top